Daily vaping of pod-based e-cigarettes alters inflammatory states across multiple organs, including the brain. The effects vary depending upon the vape flavors and influence how the body responds to infections. Mint vapes, for example, leave people more sensitive to the effects of bacterial pneumonia than mango flavoring.
Between 60-90% of people with schizophrenia smoke, compared to between 15-24% of the general population. A new study found 40% of those with schizophrenia stopped smoking traditional cigarettes after 12 weeks of switching to e-cigarettes. Researchers also reported a significant number of participants sustained their reduction in smoking or completely stopped smoking at the end of the 12-week study.
Study shows adolescents find vaping nicotine more rewarding than adults, and do so after shorter exposure. The findings may explain why vaping is so popular in the teenage demographic.
Vaping e-cigarettes modulates the oral microbiome and increases the abundance of pathobionts. The aerosols in vaping products alter the host response, prompting gum inflammation and making epithelial cells in the mouth susceptible to infection.
Researchers report allowing smokers to dictate their nicotine intake while trying to quit makes them more likely to succeed. Results suggest most smokers who use nicotine replacement medications can tolerate doses that are four times higher than normally recommended.
According to researchers, the use of e-cigarettes during pregnancy may result in facial and oral cavity defects in offspring.